These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 11277999)

  • 21. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells.
    Platzbecker U; Ward JL; Deeg HJ
    Br J Haematol; 2003 Aug; 122(3):489-97. PubMed ID: 12877678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
    Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH; Ajaz M; Lokshin A; Lee YJ
    Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities.
    Jang YJ; Park KS; Chung HY; Kim HI
    Cancer Lett; 2003 May; 194(1):107-17. PubMed ID: 12706864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
    Dudich E; Semenkova L; Dudich I; Gorbatova E; Tochtamisheva N; Tatulov E; Nikolaeva M; Sukhikh G
    Eur J Biochem; 1999 Dec; 266(3):750-61. PubMed ID: 10583368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
    Wang S; El-Deiry WS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells.
    Choi C; Kutsch O; Park J; Zhou T; Seol DW; Benveniste EN
    Mol Cell Biol; 2002 Feb; 22(3):724-36. PubMed ID: 11784850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
    Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.
    Inman GJ; Allday MJ
    J Immunol; 2000 Sep; 165(5):2500-10. PubMed ID: 10946276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity.
    Cantarella G; Uberti D; Carsana T; Lombardo G; Bernardini R; Memo M
    Cell Death Differ; 2003 Jan; 10(1):134-41. PubMed ID: 12655302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells.
    Kabore AF; Sun J; Hu X; McCrea K; Johnston JB; Gibson SB
    Apoptosis; 2006 Jul; 11(7):1175-93. PubMed ID: 16699949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
    Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
    Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
    Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
    Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
    J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.
    Kabsch K; Alonso A
    J Virol; 2002 Dec; 76(23):12162-72. PubMed ID: 12414956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.